Overview

Use of Celecoxib in Patients With Intraductal Papillary Mucinous Neoplasms (IPMNs)

Status:
Terminated
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to find out whether the drug celecoxib has beneficial effects on people with pre-cancerous lesions of the pancreas.
Phase:
Phase 2
Details
Lead Sponsor:
Indiana University School of Medicine
Treatments:
Celecoxib
Cyclooxygenase 2 Inhibitors